These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15682409)
21. Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy. Camous L; Melander C; Vallet M; Squalli T; Knebelmann B; Noël LH; Fakhouri F Am J Kidney Dis; 2008 Aug; 52(2):346-52. PubMed ID: 18572292 [TBL] [Abstract][Full Text] [Related]
22. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias. Rao A; Kelly M; Musselman M; Ramadas J; Wilson D; Grossman W; Shenoy S Pediatr Blood Cancer; 2008 Apr; 50(4):822-5. PubMed ID: 17570702 [TBL] [Abstract][Full Text] [Related]
23. Effects of rituximab on resistant SLE disease including lung involvement. Reynolds JA; Toescu V; Yee CS; Prabu A; Situnayake D; Gordon C Lupus; 2009 Jan; 18(1):67-73. PubMed ID: 19074171 [TBL] [Abstract][Full Text] [Related]
24. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
25. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144 [TBL] [Abstract][Full Text] [Related]
26. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE. Abdwani R; Mani R Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402 [TBL] [Abstract][Full Text] [Related]
27. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab. Swords R; Nolan A; Fay M; Quinn J; O'Donnell R; Murphy PT Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461 [TBL] [Abstract][Full Text] [Related]
28. Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody. Mourad YA; Taher A; Chehal A; Shamseddine A Ann Hematol; 2004 May; 83(5):319-21. PubMed ID: 15060751 [TBL] [Abstract][Full Text] [Related]
29. Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. Del Poeta G; Del Principe MI; Buccisano F; Maurillo L; Capelli G; Luciano F; Perrotti AP; Degan M; Venditti A; de Fabritiis P; Gattei V; Amadori S Cancer; 2008 Jan; 112(1):119-28. PubMed ID: 17999417 [TBL] [Abstract][Full Text] [Related]
38. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up. Rückert A; Glimm H; Lübbert M; Grüllich C Lupus; 2008 Aug; 17(8):757-60. PubMed ID: 18625656 [TBL] [Abstract][Full Text] [Related]
39. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Marcus R; Hagenbeek A Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982 [TBL] [Abstract][Full Text] [Related]
40. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]